Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry

2018108 citationsJournal Articlehybrid Open Access

Authors

Siamak Daneshmand · University of Southern California

Soroush Bazargani · University of Southern California

Trinity J. Bivalacqua · Johns Hopkins University

Jeffrey M. Holzbeierlein · University of Kansas

Brian Willard · Carolina Urology Partners

Jennifer M. Taylor · Michael E. DeBakey VA Medical Center

Joseph C. Liao

Abstract

BLC increases detection rates of carcinoma in-situ and papillary lesions over WLC alone and can change management in 14% of cases. Repeat use of HAL for BLC is safe.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Infectious Disease Case Reports and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Urologic Oncology Seminars and Original Investigations

Volume 36, Issue 8, pp. 361.e1-361.e6

DOI: 10.1016/j.urolonc.2018.04.013

Field-Weighted Citation Impact: 10.73